LBRX
LB Pharmaceuticals Inc Common Stock
NASDAQ · Healthcare · Biotechnology · US
$49.34
+3.83%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−14.5x
Market Cap
$1.59B
MomentumView details →
1D Return
+3.83%
YTD Return
+120.04%
RSI (14)
62.0
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−14.5x
Market Cap
$1.59B
RSI (14)
62.0
MomentumView details →
1D Return
+3.83%
YTD Return
+120.04%
Similar companies
Latest newsMore news →
LB Pharmaceuticals Inc. appointed Joseph M. Miller as Chief Financial Officer, effective September 2, 2026, with an annual base salary of $530,000 and a target bonus of 40% of base salary.1d agoLB Pharmaceuticals Inc reported a net loss of $51.6 million for Q2 2026, with diluted EPS of -$1.71, and cash and marketable securities of $327.8 million as of June 30, 2026.25d ago